HUE048394T2 - Új triazolopirimidinon vagy triazolopyridinone származékok és ezek felhasználása - Google Patents

Új triazolopirimidinon vagy triazolopyridinone származékok és ezek felhasználása

Info

Publication number
HUE048394T2
HUE048394T2 HUE15818399A HUE15818399A HUE048394T2 HU E048394 T2 HUE048394 T2 HU E048394T2 HU E15818399 A HUE15818399 A HU E15818399A HU E15818399 A HUE15818399 A HU E15818399A HU E048394 T2 HUE048394 T2 HU E048394T2
Authority
HU
Hungary
Prior art keywords
triazolopyrimidinone
novel
triazolopyridinone
derivatives
triazolopyridinone derivatives
Prior art date
Application number
HUE15818399A
Other languages
English (en)
Inventor
Jung Nyoung Heo
Hwan Jung Lim
Kwang Rok Kim
Kyung Jin Kim
Uk Ii Kim
Hyung Tae Bang
Ji Hye Yoon
Original Assignee
St Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Pharm Co Ltd filed Critical St Pharm Co Ltd
Publication of HUE048394T2 publication Critical patent/HUE048394T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
HUE15818399A 2014-07-11 2015-07-10 Új triazolopirimidinon vagy triazolopyridinone származékok és ezek felhasználása HUE048394T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20140087798 2014-07-11
KR1020150068375A KR101739003B1 (ko) 2014-07-11 2015-05-15 신규한 트리아졸로피리미디논 또는 트리아졸로피리디논 유도체, 및 이들의 용도

Publications (1)

Publication Number Publication Date
HUE048394T2 true HUE048394T2 (hu) 2020-07-28

Family

ID=55308036

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15818399A HUE048394T2 (hu) 2014-07-11 2015-07-10 Új triazolopirimidinon vagy triazolopyridinone származékok és ezek felhasználása

Country Status (10)

Country Link
US (1) US9914737B2 (hu)
EP (1) EP3166945B1 (hu)
JP (1) JP6257835B2 (hu)
KR (1) KR101739003B1 (hu)
CN (1) CN106488918B (hu)
DK (1) DK3166945T3 (hu)
ES (1) ES2763566T3 (hu)
HU (1) HUE048394T2 (hu)
PL (1) PL3166945T3 (hu)
PT (1) PT3166945T (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210060016A1 (en) * 2017-12-27 2021-03-04 Japanese Foundation For Cancer Research Anticancer agent
US20210121465A1 (en) * 2018-04-30 2021-04-29 Indiana University Research And Technology Corporation Ferrochelatase inhibitors and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4887139B2 (ja) * 2003-03-25 2012-02-29 武田薬品工業株式会社 ジペプチジルペプチダーゼインヒビター
US20080242661A1 (en) 2006-12-11 2008-10-02 Graeme James Dykes Novel compounds useful for the treatment of degenerative & inflammatory diseases
US9163003B2 (en) 2011-07-13 2015-10-20 Novartis Ag 4-piperidinyl compounds for use as tankyrase inhibitors
EP2831077B1 (en) 2012-03-28 2016-04-27 Merck Patent GmbH Bicyclic pyrazinone derivatives
WO2013182546A1 (en) 2012-06-07 2013-12-12 F. Hoffmann-La Roche Ag Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase
MX2014014832A (es) * 2012-06-07 2015-02-12 Hoffmann La Roche Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa.

Also Published As

Publication number Publication date
US9914737B2 (en) 2018-03-13
EP3166945A4 (en) 2018-02-14
DK3166945T3 (da) 2020-01-13
PT3166945T (pt) 2020-01-08
EP3166945A2 (en) 2017-05-17
PL3166945T3 (pl) 2020-09-07
KR101739003B1 (ko) 2017-05-23
EP3166945B1 (en) 2019-10-09
JP6257835B2 (ja) 2018-01-10
CN106488918B (zh) 2020-02-28
ES2763566T3 (es) 2020-05-29
JP2017521439A (ja) 2017-08-03
US20170145016A1 (en) 2017-05-25
KR20160007348A (ko) 2016-01-20
CN106488918A (zh) 2017-03-08

Similar Documents

Publication Publication Date Title
HK1232140A1 (zh) 微類器官以及製造和使用它們的方法
HK1231471A1 (zh) -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途
HK1254654A1 (zh) 4,6-亞嘧啶基衍生物及其用途
EP3099171A4 (en) Dihydropteridinone derivatives and uses thereof
EP3154972A4 (en) Azamophinan derivatives and use thereof
HK1232169A1 (zh) 取代的 -苯基哌啶,其製備和用途
PL3152226T3 (pl) Modyfikowane cyklopentapeptydy i ich zastosowania
GB201401617D0 (en) Novel combination and use
HK1246156B (zh) Fgf21衍生物及其用途
SG11201609490QA (en) Polymer-flavonoid conjugate and uses thereof
EP3177147A4 (en) Dihydropteridinone derivatives and uses thereof
HK1243950A1 (zh) 新型組合物和用途
GB201408673D0 (en) Medicaments,uses and methods
HK1243077A1 (zh) 呱啶基吡唑並嘧啶酮及其用途
PL3157901T3 (pl) Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
IL249122A0 (en) History of imidazole- or 4,2,1-triazole and their use
PL3386988T3 (pl) Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie
PL3166945T3 (pl) Nowe pochodne triazolopirymidynonu lub triazolopirydynonu i ich zastosowanie
EP3227293A4 (en) 6.7-cyclicmorphinan derivatives and use thereof
IL249897A0 (en) 2-oxo-4,3-dihydropyridine-5-carboxylates and their use
EP3166946A4 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
IL249073B (en) Cytin-glucan complex, its preparation and uses
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB201500278D0 (en) Novel combination and use
GB201413411D0 (en) Novel compounds and their use